The results clearly indicated that the modified PVN classification is a useful histological classification available for predicting the outcome of invasive ductal carcinoma of the breast in a manner that is independent of the nodal status, the hormone receptor status, and the adjuvant therapy status. This evidence concerns the gene NR4A1 and invasive ductal breast carcinoma.